Literature DB >> 14736547

Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide.

Christian Grohé1, Martin van Eickels, Sibylle Wenzel, Rainer Meyer, Heike Degenhardt, Pieter A Doevendans, Marcus P Heinemann, Günter Ross, Klaus-Dieter Schlüter.   

Abstract

OBJECTIVE: Parathyroid hormone-related peptide (PTHrP) expression is modulated by estrogen. It is expressed in coronary endothelial cells and involved in the endothelium-dependent regulation of coronary resistance and cardiac function. In the present study, we hypothesized that endogenously synthesized and released PTHrP contributes to sex-specific differences in the regulation of cardiac function.
METHODS: The influence of sex on ventricular PTHrP expression in normotensive rats was determined via real-time PCR and immunoblot analysis. Sex-specific effects of exogenous PTHrP or endogenous released PTHrP were determined in vitro on isolated ventricular cardiomyocytes, Langendorff preparations on isolated hearts and in vivo using different agonistic or antagonistic PTHrP peptides.
RESULTS: Ventricular expression of PTHrP was elevated in hearts from female rats compared to male counterparts. Addition of PTHrP(1-36) did not increase left ventricular function in hearts from either sex, but increased coronary flow in hearts from female rats significantly greater than in those from males. 5Ile-PTHrP(1-36), which was used to antagonize endogenously released PTHrP, reduced left ventricular function in females but not males in vitro and in vivo. Under conditions of increased endogenous PTHrP release, i.e. ischemia-reperfusion, antagonization of PTHrP significantly reduced post-ischemic recovery in hearts from females but not in those from males.
CONCLUSIONS: Sex determines the ventricular expression of PTHrP mRNA and protein. The results indicate that PTHrP may improve cardiac function to a greater extent in women than in men following a brief period of ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736547     DOI: 10.1016/j.cardiores.2003.11.025

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

1.  Mechanisms by which calcium receptor stimulation modifies electromechanical coupling in isolated ventricular cardiomyocytes.

Authors:  Rolf Schreckenberg; Elena Dyukova; Guzel Sitdikova; Yaser Abdallah; Klaus-Dieter Schlüter
Journal:  Pflugers Arch       Date:  2014-04-01       Impact factor: 3.657

2.  Modulation of receptor sensitivity: possible therapeutic target?

Authors:  Michel V Cohen; James M Downey
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

3.  Understanding estrogen action during menopause.

Authors:  Jameel Iqbal; Mone Zaidi
Journal:  Endocrinology       Date:  2009-08       Impact factor: 4.736

4.  Rat intermedin1-47 does not improve functional recovery in postischemic hearts.

Authors:  Gerald Münzel; Alexander Schlier; Rolf Schreckenberg; Yaser Abdallah; Klaus-Dieter Schlüter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-01       Impact factor: 3.000

5.  Calcium-sensing receptor: a sensor and mediator of ischemic preconditioning in the heart.

Authors:  Junhui Sun; Elizabeth Murphy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-10       Impact factor: 4.733

6.  Parathyroid Hormone-Related Peptide and Its Analog, Abaloparatide, Attenuate Lethal Myocardial Ischemia-Reperfusion Injury.

Authors:  Joseph Wider; Vishnu V R Undyala; Beate Lanske; Nabanita S Datta; Karin Przyklenk
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.964

7.  Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes.

Authors:  M Fontana; H Olschewski; A Olschewski; K-D Schlüter
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

8.  Post-conditioning restores pre-ischaemic receptor coupling in rat isolated hearts.

Authors:  Rolf Schreckenberg; Thorsten Maier; Klaus-Dieter Schlüter
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.